Cited 0 time in
Korean guidelines for the management of gout
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Lee, Jennifer Jooha | - |
| dc.contributor.author | Lee, Ji Soo | - |
| dc.contributor.author | Chung, Min Kyung | - |
| dc.contributor.author | Ahn, Joong Kyong | - |
| dc.contributor.author | Choi, Hyo-Jin | - |
| dc.contributor.author | Hong, Seung-Jae | - |
| dc.contributor.author | Yoon, Chong-Hyeon | - |
| dc.contributor.author | Kim, Su-Hyun | - |
| dc.contributor.author | Jeong, Kyung-Hwan | - |
| dc.contributor.author | Kim, Jong-Woo | - |
| dc.contributor.author | Kim, Bo-Yeon | - |
| dc.contributor.author | Shin, Jin-Ho | - |
| dc.contributor.author | Kim, Woo Gyu | - |
| dc.contributor.author | Kim, Soo-Young | - |
| dc.contributor.author | Kim, Hyun-Jung | - |
| dc.contributor.author | Song, Jeong-Soo | - |
| dc.contributor.author | Jun, Jae-Bum | - |
| dc.contributor.author | Park, Hyun-Ah | - |
| dc.contributor.author | Chae, Shung Chull | - |
| dc.contributor.author | Choi, Bum Soon | - |
| dc.contributor.author | Kim, Tae Nyun | - |
| dc.contributor.author | Kim, Hyun Ah | - |
| dc.date.accessioned | 2026-03-05T01:00:40Z | - |
| dc.date.available | 2026-03-05T01:00:40Z | - |
| dc.date.issued | 2023-07 | - |
| dc.identifier.issn | 2093-940X | - |
| dc.identifier.issn | 2233-4718 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/211072 | - |
| dc.description.abstract | Gout is the most common form of arthritis, with the prevalence increasing worldwide. The present treatment guidelines provide recommendations for the appropriate treatment of acute gout, management during the inter-critical period, and prevention of chronic complications. The guidelines were developed based on evidence-based medicine and draft recommendations finalized after expert consensus. These guidelines are designed to provide clinicians with clinical evidence to enable efficient treatment of gout. | - |
| dc.format.extent | 10 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | 대한류마티스학회 | - |
| dc.title | Korean guidelines for the management of gout | - |
| dc.type | Article | - |
| dc.publisher.location | 대한민국 | - |
| dc.identifier.doi | 10.4078/jrd.2023.0029 | - |
| dc.identifier.scopusid | 2-s2.0-105028001872 | - |
| dc.identifier.wosid | 001024759700002 | - |
| dc.identifier.bibliographicCitation | 대한류마티스학회지, v.30, no.3, pp 141 - 150 | - |
| dc.citation.title | 대한류마티스학회지 | - |
| dc.citation.volume | 30 | - |
| dc.citation.number | 3 | - |
| dc.citation.startPage | 141 | - |
| dc.citation.endPage | 150 | - |
| dc.type.docType | Review | - |
| dc.identifier.kciid | ART002968757 | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.description.journalRegisteredClass | esci | - |
| dc.description.journalRegisteredClass | kci | - |
| dc.relation.journalResearchArea | Rheumatology | - |
| dc.relation.journalWebOfScienceCategory | Rheumatology | - |
| dc.subject.keywordPlus | URATE-LOWERING THERAPY | - |
| dc.subject.keywordPlus | SERUM URIC-ACID | - |
| dc.subject.keywordPlus | DOUBLE-BLIND | - |
| dc.subject.keywordPlus | FLARE PREVENTION | - |
| dc.subject.keywordPlus | INITIATION | - |
| dc.subject.keywordPlus | ALLOPURINOL | - |
| dc.subject.keywordPlus | RISK | - |
| dc.subject.keywordPlus | FEBUXOSTAT | - |
| dc.subject.keywordPlus | COLCHICINE | - |
| dc.subject.keywordPlus | PROPHYLAXIS | - |
| dc.subject.keywordAuthor | Gout | - |
| dc.subject.keywordAuthor | Guidelines | - |
| dc.subject.keywordAuthor | Treatment | - |
| dc.identifier.url | https://www.jrd.or.kr/journal/view.html?doi=10.4078/jrd.2023.0029 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
